Entero Healthcare Solutions Ltd

Entero Healthcare Solutions Ltd

$ENTEROPharmacy RetailNSEBSE

Entero Healthcare Solutions Ltd (ENTERO) last traded at ₹1,632, a market capitalisation of ₹7,102 crore, on a P/E of 55.0. Over the past 52 weeks the stock has ranged between ₹944 and ₹1,665. Entero Healthcare Solutions Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,940 crore and net profit of ₹52 crore. The next scheduled event is an analyst meet on 2 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Entero Healthcare Solutions Ltd share price and key metrics

Current price
₹1,632
Market cap
₹7,102 cr
Stock P/E
55.0
Book value
₹388
ROE
6.94%
ROCE
10.5%
Dividend yield
0.00%
52w high / low
1665/944

Metrics as of 25 Aug 2026. Not real time.

Entero Healthcare Solutions Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹1,940 cr, up 38.2% from ₹1,404 cr a year earlier. Net profit was ₹52 cr, up 73.3% year on year.

Entero Healthcare Solutions Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,3011,3591,3391,4041,5711,7071,9101,940
Expenses1,2581,3091,2901,3541,5091,6391,8241,844
Operating profit4250495062688697
OPM %3.3%3.7%3.6%3.6%4.0%4.0%4.5%5%
Other income118765-443
Interest1110101112141721
Depreciation788910101512
Profit before tax3539373645405867
Tax %25%25%16%17%18%16%22%22%
Net profit2629313037344552
EPS (₹)5.435.855.906.397.266.356.448.77

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Entero Healthcare Solutions Ltd annual results

Entero Healthcare Solutions Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,7732,5223,3003,9225,0966,5917,128
Operating profit152464112172266313
OPM %0.8%1.0%1.9%2.9%3.4%4.0%4.4%
Net profit-15-29-1140107146168
EPS (₹)-1,550.90-77.71-28.128.9921.7926.4428.82

TTM is the trailing twelve months to the most recent quarter.

Entero Healthcare Solutions Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
30%
3 Years
26%
TTM
32%
Compounded Profit Growth
10 Years
%
5 Years
57%
3 Years
130%
TTM
26%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
25%
Return on Equity
10 Years
%
5 Years
%
3 Years
6%
Last Year
7%

Entero Healthcare Solutions Ltd shareholding pattern

Promoters held 52.40% at Jun 2026, broadly unchanged since Jun 2025. FIIs 4.36% and DIIs 15.48%.

Entero Healthcare Solutions Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters52.44%52.44%52.42%52.42%52.42%52.42%52.42%52.40%
FIIs23.82%22.20%19.92%17.21%14.68%5.14%4.03%4.36%
DIIs7.73%8.78%9.63%10.19%9.64%16.42%16.62%15.48%
Public16.02%16.59%18.03%20.19%23.26%26.03%26.94%27.77%
No. of shareholders36,76733,17233,15933,33836,33440,33339,08439,709

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Upcoming Entero Healthcare Solutions Ltd events

The next scheduled event is an analyst meet on 2 Sept 2026.

  • Analyst meetAnalyst / Institutional Investor meetings at an Investor Conference

See the full results calendar for every Indian company reporting in the next 30 days.

Entero Healthcare Solutions Ltd corporate filings

  • Intimation of Schedule of Analyst/Institutional Investor meetingsCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions has issued an intimation regarding scheduled meetings with…

    Read the full analysis
  • Completion of tenure of Mr. Rajesh Shashikant DalalCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited has formally announced that Mr. Rajesh Shashikant…

    Read the full analysis
  • Proceedings of Annual General Meeting held on Wednesday, August 19, 2026.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited has successfully concluded its 8th Annual General…

    Read the full analysis
  • Transcript of Earnings Call / Conference CallCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited reported a strong start to FY27 with consolidated…

    Read the full analysis
  • Recording of Earnings Call/ Conference Call on Unaudited Financial Results of the Company for the quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited has formally notified the stock exchanges regarding…

    Read the full analysis
  • Newspaper publication for Unaudited Financial Results for the quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited has released its unaudited financial results for the…

    Read the full analysis
  • Investor Presentation on Unaudited Financial Results for the Quarter ended June 30, 2026Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited reported a robust Q1 FY27, with consolidated revenue…

    Read the full analysis
  • Outcome of Board Meeting held on August 07, 2026Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited reported consolidated revenue from operations of…

    Read the full analysis
  • Revised intimation of the Earnings Call on the unaudited Financial results of the Company for the quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited has issued a revised intimation regarding its…

    Read the full analysis
  • Intimation of Earnings call on Unaudited Financial Results of the Company for the quarter ended June 30, 2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Entero Healthcare Solutions Limited has announced an earnings conference call to discuss…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Entero Healthcare Solutions Ltd

Cruxal reads every Entero Healthcare Solutions Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Entero Healthcare Solutions Ltd (ENTERO) Results, Financials & Share Price | Cruxal